Symptoms
Common signs and symptoms of Ependymoma include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Ependymoma.
The exact cause of ependymomas remains largely unknown, which can be frustrating for families seeking answers.
The exact cause of ependymomas remains largely unknown, which can be frustrating for families seeking answers. These tumors develop when ependymal cells begin growing and dividing uncontrollably. Think of it like a photocopier that gets stuck making copies - the normal cell reproduction process goes awry, creating too many cells that form a mass.
Genetic factors play a role in some cases.
Genetic factors play a role in some cases. Researchers have identified certain genetic mutations and chromosomal changes in ependymoma cells, but these are usually acquired during a person's lifetime rather than inherited. A small percentage of cases are associated with inherited conditions like neurofibromatosis type 2, but the vast majority occur randomly without any family history.
Environmental factors have not been definitively linked to ependymoma development.
Environmental factors have not been definitively linked to ependymoma development. Unlike some other cancers, there's no clear connection to radiation exposure, chemicals, or lifestyle factors. This randomness often brings relief to parents wondering if something they did caused their child's tumor, while also highlighting how unpredictable these conditions can be.
Risk Factors
- Age under 5 years or between 40-60 years
- Male gender (slightly higher risk)
- Neurofibromatosis type 2 genetic condition
- Previous radiation treatment to the head or spine
- Family history of brain tumors (rare)
- Certain inherited genetic syndromes
- Prior history of other central nervous system tumors
Diagnosis
How healthcare professionals diagnose Ependymoma:
- 1
Diagnosing ependymoma typically begins when symptoms prompt a visit to the doctor, often starting with a pediatrician or family physician.
Diagnosing ependymoma typically begins when symptoms prompt a visit to the doctor, often starting with a pediatrician or family physician. The initial evaluation includes a thorough neurological examination, checking reflexes, coordination, vision, and cognitive function. If concerns arise, referral to a neurologist or neurosurgeon follows quickly.
- 2
Magnetic resonance imaging (MRI) serves as the gold standard for diagnosing ependymomas.
Magnetic resonance imaging (MRI) serves as the gold standard for diagnosing ependymomas. This detailed scan reveals the tumor's size, exact location, and relationship to surrounding brain or spinal cord structures. Doctors often use contrast dye to enhance the images, making the tumor boundaries clearer. Additional MRI scans of the entire brain and spine help determine if the tumor has spread to other areas.
- 3
Confirming the diagnosis requires a tissue sample, usually obtained through surgical biopsy or during tumor removal surgery.
Confirming the diagnosis requires a tissue sample, usually obtained through surgical biopsy or during tumor removal surgery. A pathologist examines the cells under a microscope and performs specialized tests to determine the specific type and grade of ependymoma. Modern molecular testing can identify genetic markers that help predict how the tumor might behave and respond to treatment. Lumbar puncture may be performed to check if tumor cells are present in the cerebrospinal fluid.
Complications
- Complications from ependymomas can arise from the tumor itself, its treatment, or both.
- The tumor's location often determines potential problems - those in the brain may cause hydrocephalus (fluid buildup), while spinal ependymomas can lead to weakness or paralysis.
- Many patients require a shunt to drain excess cerebrospinal fluid, which carries its own risks of infection or malfunction.
- Treatment-related complications vary by approach and patient age.
- Surgery may result in neurological deficits, though these are often temporary.
- Radiation therapy can cause cognitive changes in children, hearing problems, or secondary tumors years later.
- The risk of recurrence remains a concern, particularly for incompletely removed tumors, with most recurrences happening within the first few years after treatment.
Prevention
- Currently, there are no known ways to prevent ependymomas from developing.
- Unlike some cancers linked to lifestyle factors or environmental exposures, ependymomas appear to occur randomly in most cases.
- This reality can be difficult to accept, especially for parents of affected children who naturally want to know what they could have done differently.
- The focus instead shifts to early detection and optimal treatment.
- Being aware of warning signs and seeking prompt medical evaluation for persistent neurological symptoms represents the most practical approach.
- For families with rare genetic conditions like neurofibromatosis type 2, regular monitoring with MRI scans may help detect tumors early.
- Ongoing research into the genetic and molecular basis of ependymomas may eventually lead to prevention strategies.
- Scientists are studying why certain cells become cancerous and whether this process could be interrupted.
- Until then, supporting research through participation in studies and advocacy helps advance our understanding of these challenging tumors.
Treatment for ependymoma almost always begins with surgery, aiming to remove as much of the tumor as safely possible.
Treatment for ependymoma almost always begins with surgery, aiming to remove as much of the tumor as safely possible. Complete removal offers the best chance for long-term control, but this isn't always achievable depending on the tumor's location. Neurosurgeons use advanced techniques including intraoperative MRI and neurological monitoring to maximize removal while protecting critical brain and spinal cord functions.
Radiation therapy typically follows surgery, especially when complete removal wasn't possible or for higher-grade tumors.
Radiation therapy typically follows surgery, especially when complete removal wasn't possible or for higher-grade tumors. Modern radiation techniques like intensity-modulated radiation therapy (IMRT) and proton beam therapy allow precise targeting while minimizing damage to healthy tissue. For young children under 3, doctors often try to delay radiation due to potential effects on the developing brain.
Chemotherapy plays a more limited role in ependymoma treatment compared to other brain tumors.
Chemotherapy plays a more limited role in ependymoma treatment compared to other brain tumors. It's sometimes used for very young children to delay radiation, for recurrent tumors, or in clinical trials testing new approaches. Current chemotherapy drugs show modest effectiveness, leading researchers to explore targeted therapies based on specific genetic changes found in different ependymoma subtypes.
Emerging treatments include immunotherapy and drugs targeting specific molecular pathways.
Emerging treatments include immunotherapy and drugs targeting specific molecular pathways. Clinical trials are investigating medications that block tumor blood vessel formation and agents that target cancer stem cells. For patients with recurrent ependymomas, reoperation combined with advanced radiation techniques or experimental treatments through clinical trials offers hope for continued disease control.
Living With Ependymoma
Living with ependymoma requires adapting to a new reality while maintaining hope and quality of life. Regular follow-up care becomes a permanent part of life, typically involving MRI scans every few months initially, then less frequently over time. These scans can create anxiety, but they're essential for catching any recurrence early when treatment options remain most effective.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Mar 31, 2026v1.0.0
- Published by DiseaseDirectory